- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Synthesis of JAK2 Inhibitor BMS-911543 ; volume:11 ; number:09 ; year:2015 ; pages:0899-0899
Synfacts ; 11, Heft 09 (2015), 0899-0899
- DOI
-
10.1055/s-0034-1378765
- URN
-
urn:nbn:de:101:1-2019011106172511513952
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Ähnliche Objekte (12)
Synthesis of BMS-741672
Synthesis of BMS-663068
Synthesis of BMS-932481
Synthesis of BMS-644950
Synthesis of BMS-741672
Synthesis of BMS-986158
Commercial Synthesis of BMS-663068
Synthesis of the Tricyclic Core of BMS-986251
Der JAK2-Inhibitor Fedratinib : Myelofibrose Therapie neu denken
Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2 V617F-induced myeloproliferative neoplasms
Correction to: Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2 V617F-induced myeloproliferative neoplasms
Effect of the JAK2/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres
Synthesis of BMS-741672
Synthesis of BMS-663068
Synthesis of BMS-932481
Synthesis of BMS-644950
Synthesis of BMS-741672
Synthesis of BMS-986158
Commercial Synthesis of BMS-663068
Synthesis of the Tricyclic Core of BMS-986251
Der JAK2-Inhibitor Fedratinib : Myelofibrose Therapie neu denken
Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2 V617F-induced myeloproliferative neoplasms
Correction to: Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2 V617F-induced myeloproliferative neoplasms
Effect of the JAK2/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres
Synthesis of BMS-741672
Synthesis of BMS-663068
Synthesis of BMS-932481
Synthesis of BMS-644950
Synthesis of BMS-741672
Synthesis of BMS-986158
Commercial Synthesis of BMS-663068
Synthesis of the Tricyclic Core of BMS-986251
Der JAK2-Inhibitor Fedratinib : Myelofibrose Therapie neu denken
Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2 V617F-induced myeloproliferative neoplasms
Correction to: Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2 V617F-induced myeloproliferative neoplasms